Projects funded by the NCN
Indication of biological factors related to lower sensitivity to trastuzumab in HER2-overexpressing breast cancer patients.
2013/09/B/NZ5/00764
Keywords:
Breast cancer patients HER2 overexpression lower sensitivity to trastuzumab
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
- NZ5_5: Diagnostics in human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Krakowie
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 14
Call: OPUS 5 - announced on 2013-03-15
Amount awarded: 850 547 PLN
Project start date (Y-m-d): 2014-02-24
Project end date (Y-m-d): 2018-02-23
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled